Figure 3. .

Clinical course of 23 fully informative, nonmosaic FA-D2 patients in this study. A, The cumulative incidence of BMF of the FA-D2 patients in the present study (FA-D2) precedes that of all patients with FA in the IFAR⁴² (P=.001). B, The period from BMF to HSCT, which was shorter in the patients of the present study than in those of the IFAR⁴² (trending, P<.08). C, Cumulative incidence of HSCT of the FA-D2 patients in our study, which likewise antedates that of all patients in the IFAR⁴² (P<.01). D, Kaplan-Meier curves of survival, which suggest higher death rates of the FA-D2 patients than of all patients in the IFAR aged >10 years.